Search   Advanced Search
LATEST NEWS
 
 
News
 Latest Headlines
 Quick Facts
 Breaking News
 Top Stories
 Feature Articles
 Politics
 US Policy
 General
 Commodities
 Canadian
 UK
 Indian
 Wallstreet Events
 US Economic News
 European Economic News
 Asian Economic News
 All Economic News
 FX Top Stories
 Currency Alerts
 Mkt Sensitive News
 Politics
 European Mkt Updates
 Asian Mkt Updates
 Treasury Mkt Updates
 Pop
 Rock
 Classic Rock
 Rap/Hip-Hop
 Country
 Alternative
 Oldies
 Movie Reviews
 DVD Releases
 Box Office
 Slide Shows
 Business News
Commentary/Analysis
 Daily Market Analysis
 US Market Updates
 US Commentary
 Asian Commentary
 European Commentary
 Canadian Commentary
 Indian Commentary
 Sector/Market Trends
Stock Alerts
 Stocks To Watch
 Long Term Stocks
 Before the Bell
 $5 and Under
 After the Bell
 Intraday Updates
 IPOs
 Hot Stocks
Earnings Calendars
 Upcoming Earnings
 Latest Earnings
 Pos Pre Announcements
 Neg Pre Announcements
Corporate Calendars
 Stock Splits
 Stock Buybacks
 Dividends
 Conference Calls
 FDA Calendar
 Board Meetings
 Mergers & Acquisitions
Ratings Changes
 Upgrades
 Downgrades
 Coverage Initiations
 Coverage Reiterated
 All Videos
 Market Commentary
 Top Stories
 Economic News
 Political News
 Foreign Markets
 Corporate News
 Entertainment News
 Top Stories
 Earnings
 Mergers & Acquisitions
 Market Commentary
 Economic News
 IPOs and New Issues
 Corporate News
 Forex News
 Interviews
 Private Equity
Economic Calendar
RTT DeskAlert
Font Down Font Up

 
Complete Production Slips To Loss In Q3 On Charges, Lower Revenue - Update
10/26/2009 8:46 PM  ET

RELATED NEWS
Complete Production Services Slips To Loss In Q3 - Quick Facts
TOP MARKET NEWS
Stocks Close Mostly Lower Amid Disappointing Quarterly Results - U.S. Commentary
Stocks Remain Stuck In The Red In Mid-Afternoon Trading - U.S Commentary
Stocks Posting Moderate Losses In Early Afternoon Trading - U.S. Commentary
New Guidelines Recommend Women Wait Until 21 For Cervical Cancer Screening
Stocks Seeing Further Downside In Late Morning Trading - U.S. Commentary
(RTTNews) -  Oilfield services provider Complete Production Services Inc. (CPX: News ) on Monday reported a net loss for the third quarter compared to a profit in the year-ago period, hurt by revenues that more than halved from last year, and on charges related to fixed asset impairment.

The company's net loss for the third quarter was $52.03 million, or $0.69 per share, compared to net income of $52.32 million, or $0.70 per share, in the same period last year.

The latest quarter's results include pre-tax, non-cash charges of $41.0 million primarily related to fixed assets. The charges resulted from an ongoing evaluation and rationalization of operations and assets due to significant changes in market conditions that began in the fourth quarter of 2008.

The contract drilling business accounted for about $37.6 million of the total charges, of which $36.2 million related to an impairment analysis done in accordance with U.S. GAAP and $1.4 million resulted from asset disposals. The remaining $3.4 million of the charges occurred within the Completion and Production Services segment and was associated with asset disposals and inventory write-downs.

Excluding these charges, net loss for the quarter was $0.32 per share. On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.32 per share for the quarter. Analysts' estimates typically exclude special items.

Revenues for the quarter dropped 53.49% to $229.91 million from $494.31 million in the prior-year quarter. Analysts had a consensus revenue estimate of $230.67 million for the quarter.

Services revenue for the quarter were $223.43 million, down from $481.07 million a year ago. Products revenue for the quarter declined to $6.48 million from $13.24 million in the same period last year.
Depreciation and amortization expenses for the quarter were $50.38 million, up from $47.72 million a year ago. Fixed asset impairment loss for the quarter was $36.16 million.

Loss from continuing operations for the quarter was $52.03 million, or $0.69 per share, compared to income from continuing operations of $52.47 million, or $0.70 per share, a year ago.

On a segmental basis, revenue for the Completion and Production Services segment during the third quarter fell 52.7% to $198.01 million from $418.87 million in the same period last year. Adjusted EBITDA for the quarter was $31.40 million, down from $133.46 million a year ago.

Drilling services revenues fell 59.1% to $25.42 million from $62.21 million a year ago. Adjusted EBITDA for the quarter was a loss of $3.76 million compared to positive EBITDA of $17.01 million in the prior-year period.

To receive FREE breaking news email alerts for COMPLETE PRODUCTION SERV and others in your portfolio


 1   2   Next Page 


Share Article:   Del.icio.us    Digg    Y! My Web    Facebook    My Space

Email        Print        

     
  Trading Center
 

More Breaking News-US

74  FDA Approves Bristol-Myers' Abilify To Treat Irritabilty In Pediatric Patients With Autistic Disorder - Update
73  EU Extends Review Deadline For Oracle's Proposed Takeover Of Sun Micro - Update
72  Pfizer's Geodon Approved As Adjunctive For Bipolar Disorder - Update
71  CF Nominees Enter Terra's Board - Update
70  Archipelago Learning Prices IPO Within Expected Range; Stock Soars - Update
69  Brown University And IBM Launch Multimillion-Dollar Supercomputer - Update
68  GLG Life Tech Starts Trading On Nasdaq; Shares Down 13.7% - Update
67  Global Defense Technology Prices IPO At $13/Share, Below Prior Estimate - Update
66  Dendreon Gets FDA Acceptance For Prostrate Cancer Drug Application - Update
65  Covidien's Pain Drug NDA Review Extended By FDA - Update
64  Inovio's Pre-clinincal Study Of Universal Flu Vaccines Reports Protective Response Against Multiple Influenza Strains; Stock Up - Update
63  Cloud Peak Energy Prices IPO At $15/shr - Update
62  Met-Pro Q3 Profit Plunges - Update
61  Boston Scientific Receives FDA's 510 (k)Clearance For WallFlex Fully Covered Esophageal Stent - Update
60  Pfizer Granted FDA Approval For Intravenous Formulation Of Revatio - Update
  

 

Copyright © 2009 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service.

Feedback| Terms of Service | How To Use RTTNews.com| Advertise| Buy Content | RSS